Cargando…

Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient

Introduction: Activated phosphoinositide 3-kinase-δ syndrome 2 (APDS2) is a rare primary immune regulatory disorder caused by heterozygous gain of function mutation in the PIK3R1 gene encoding PI3Kδ regulatory p85α subunit and resulting in PI3Kδ hyperactivation. Clinical features range from recurren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conti, Francesca, Catelli, Arianna, Cifaldi, Cristina, Leonardi, Lucia, Mulè, Rita, Fusconi, Marco, Stefoni, Vittorio, Chiriaco, Maria, Rivalta, Beatrice, Di Cesare, Silvia, Schifino, Gioacchino, Sbrega, Fabiana, Di Matteo, Gigliola, Ferrari, Simona, Cancrini, Caterina, Pession, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295470/ https://www.ncbi.nlm.nih.gov/pubmed/34307262 http://dx.doi.org/10.3389/fped.2021.702546

Ejemplares similares

Corrigendum: Case Report: Hodgkin Lymphoma and Refractory Systemic Lupus Erythematosus Unveil Activated Phosphoinositide 3-Kinase-δ Syndrome 2 in an Adult Patient
por: Conti, Francesca, et al.
Publicado: (2021)

JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long‐known gene
por: Di Matteo, Gigliola, et al.
Publicado: (2018)

Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies
por: Attardi, Enrico, et al.
Publicado: (2019)

Activated phosphoinositide 3‐dinase delta syndrome (APDS): An update
por: Lougaris, Vassilios, et al.
Publicado: (2022)

Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up
por: Rivalta, Beatrice, et al.
Publicado: (2021)

Immunological Aspects of X-Linked Chronic Granulomatous Disease Female Carriers
por: Chiriaco, Maria, et al.
Publicado: (2021)

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
por: Maccari, Maria Elena, et al.
Publicado: (2018)

Novel X-Linked Inhibitor of Apoptosis Mutation in Very Early-Onset Inflammatory Bowel Disease Child Successfully Treated with HLA-Haploidentical Hemapoietic Stem Cells Transplant after Removal of αβ(+) T and B Cells
por: Cifaldi, Cristina, et al.
Publicado: (2017)

Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients
por: Cifaldi, Cristina, et al.
Publicado: (2021)

First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia
por: Chiriaco, Maria, et al.
Publicado: (2019)

Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment
por: Zangari, Paola, et al.
Publicado: (2019)

Targeted treatment of autoimmune cytopenias in primary immunodeficiencies
por: Pacillo, Lucia, et al.
Publicado: (2022)

Unveiling molecular insights into the mechanism of activation of oncogenic phosphoinositide 3-kinase mutants
por: Krimmer, Stefan G., et al.
Publicado: (2022)

Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ
por: Somoza, John R., et al.
Publicado: (2015)

Deconvolution of bulk RNA sequencing in activated phosphoinositide 3‐kinase δ syndrome
por: Huang, Xia, et al.
Publicado: (2023)

Host Defenses to Viruses: Lessons from Inborn Errors of Immunity
por: Leonardi, Lucia, et al.
Publicado: (2022)

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
por: Coulter, Tanya I., et al.
Publicado: (2017)

Occurrence of B-cell lymphomas in patients with Activated Phosphoinositide 3-Kinase δ syndrome
por: Kracker, Sven, et al.
Publicado: (2014)

Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration
por: Ali, Ahmed Y., et al.
Publicado: (2018)

Phosphoinositide 3-kinase δ regulates membrane fission of Golgi carriers for selective cytokine secretion
por: Low, Pei Ching, et al.
Publicado: (2010)

Case Report: First Occurrence of Plasmablastic Lymphoma in Activated Phosphoinositide 3-Kinase δ Syndrome
por: Yin, Zexi, et al.
Publicado: (2021)

Respiratory treatment in a patient with nemaline myopathy
por: Polastri, Massimiliano, et al.
Publicado: (2019)

Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
por: Khadem, Forough, et al.
Publicado: (2014)

Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8(+) T Cell Survival, Differentiation, and Function
por: Cannons, Jennifer L., et al.
Publicado: (2018)

Airway epithelial phosphoinositide 3-kinase-δ contributes to the modulation of fungi-induced innate immune response
por: Jeong, Jae Seok, et al.
Publicado: (2018)

Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease
por: Xie, Tao, et al.
Publicado: (2023)

Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase δ syndrome 1
por: Jiang, Lu, et al.
Publicado: (2023)

Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants
por: Baccelli, Francesco, et al.
Publicado: (2022)

Non-invasive respiratory supports on inspiratory effort in COVID-19: How and when is it matter of selection? Author's reply.
por: Schifino, Gioacchino, et al.
Publicado: (2022)

Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies
por: Amodio, Donato, et al.
Publicado: (2021)

Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease
por: Ando, Kunie, et al.
Publicado: (2021)

Inhibition of Phosphoinositide 3-Kinase/Protein Kinase B Signaling Hampers the Vasopressin-dependent Stimulation of Myogenic Differentiation
por: Sorrentino, Silvia, et al.
Publicado: (2019)

Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts
por: Ying, Huijun, et al.
Publicado: (2012)

PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis
por: Pollock, Claire B., et al.
Publicado: (2011)

Phosphoinositide 3-kinase-δ regulates fungus-induced allergic lung inflammation through endoplasmic reticulum stress
por: Lee, Kyung Sun, et al.
Publicado: (2016)

The Predictive Role of Biomarkers and Genetics in Childhood Asthma Exacerbations
por: di Palmo, Emanuela, et al.
Publicado: (2021)

Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait?
por: Chiriaco, Maria, et al.
Publicado: (2022)

The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies
por: Desimio, Maria G., et al.
Publicado: (2023)

Phosphoinositides and phagocytosis
por: Gillooly, David J., et al.
Publicado: (2001)

Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection
por: Brigida, Immacolata, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jc1mh1si3md9amfigsgmb6a25f